We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Alexander Beadle

Science Writer

Contact Us


Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds an MChem in materials chemistry from the University of St Andrews, where he won a Chemistry Purdie Scholarship and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.

Latest Content From Alexander Beadle

New Research Sheds Light on How Long Cannabis Impairment Lasts

In a new meta-analysis of past cannabis impairment studies, researchers at the University of Sydney have identified a “window of impairment” following medium and high-dose cannabis use, during which users should avoid driving.


Cannabis Advertising Linked to Problematic Use in Teens, Study Claims

Teens who frequently see billboard or storefront advertising for recreational cannabis products are more likely to use the drug weekly and to have symptoms of cannabis use disorder, according to new research.


CT Scans Reveal Higher Rates of Emphysema in Cannabis Smokers

Cannabis smokers experience emphysema at higher rates than both non-smokers and tobacco smokers, according to new research from the Ottawa Hospital.


Cannabis Legalization Associated with Increase in Driving Accidents

This “small but significant increase” in fatal motor vehicle accidents and fatalities could be curbed by effective regulations and educational campaigns, according to researchers.


Is Delta-8-THC a Legal High?

Delta-8-THC is growing in popularity across North America. But how is it different to its more famous cousin, Delta-9-THC? What are its effects? And is it, like many are claiming, federally legal in the US?


AOAC Opens Call for Toxin Screening Methods in Cannabis Materials

AOAC International is now inviting submissions from cannabis laboratories with unique methods for mycotoxin screening and for the detection of Shiga toxin-producing Escherichia coli in cannabis plant materials and derivatives.


More Evidence Needed to Support Medical Cannabis Use for Pain, Say Experts

The International Association for the Study of Pain says it cannot currently endorse the general use of cannabis and cannabinoids for pain relief based on a lack of high-quality evidence.


FDA Issues Warning Letters to Two Companies Selling CBD Products for Pain Relief

California’s Honest Globe, Inc. and Michigan’s BioLyte Laboratories, LLC, have become the latest in a long line of companies to receive official warning letters from the FDA for the illegal marketing of unapproved CBD-containing drugs.


Medical Cannabis Can Reduce Tremors, Finds Animal Study

A synthetic cannabinoid with similar properties to THC can effectively reduce essential tremor in mice, according to a new study from researchers.


Vitamin E Acetate Found in a Popular European CBD Vape Products, Study Finds

The diluent thickener, which is thought to be the culprit behind the outbreak of vaping-related lung injuries seen in the United States in 2019, has been discovered in one of Europe’s most popular CBD vape products.